Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02844231
Other study ID # UF 8585
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2010
Est. completion date December 31, 2017

Study information

Verified date May 2024
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sleepwalking (also called somnambulism) is a disorder in which only SWS is disrupted. This NREM parasomnia is characterized by inappropriate motor behaviors, usually initiated during arousal from SWS, that induce psychological distress and alter quality of life, leading to fatigue, excessive daytime sleepiness, and objectively impaired vigilance in the morning. The pathophysiology of sleepwalking remains poorly understood. Sleepwalkers had difficulty maintaining stable, consolidated sleep and experienced more arousals and microarousals, specifically from SWS, leading to increased NREM instability, especially during the first sleep cycles. The brain is partially awake, resulting in behavioral manifestations, and partially in NREM sleep, resulting in no conscious awareness of actions. A Single Photonic Emission Computed Tomography (SPECT) study of one sleepwalking episode found increased activation in the posterior cingulate cortex and cerebellum, with deactivation in the frontoparietal associative cortices. Data from intracerebral EEGs during confusional arousals confirmed both local arousal of the motor and cingulate cortices and increased delta activity in the frontoparietal associative cortices. The investigators thus proposed a controlled study of SPECT imagery in 24 sleepwalkers (12 SPECT during a SW episode and 12 SPECT during slow wave sleep and 24 during wakefulness) and 12 controls (during slow wave sleep and wakefulness). SW episodes will be elicited by sleep deprivation condition associated with forced arousal (auditory stimulus). The comparative analyses of SPECT acquisitions between different states (wakefulness, slow wave sleep and SW) and populations (sleepwalkers versus controls) will provide new insights about the complex pathophysiology of SW episodes.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date December 31, 2017
Est. primary completion date June 6, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 39 Years
Eligibility PATIENTS Inclusion Criteria: - Subject diagnosed with NREM parasomnia according the international classification of sleep disorders - More than one episode per week - More than one hypersynchronous delta wave arousal recorded on polysomnographic assessment - Affiliated to social security - Age between 18 years-old and 39 years-old Exclusion Criteria: - Patient taking any psychotropic drug during the two weeks before the inclusion - Patient with obstructive sleep apnea Syndrome, restless legs syndrome, nocturnal epilepsy and unstable psychiatric disease. CONTROL GROUP Inclusion Criteria: - Affiliated to social security - Age between 18 years-old and 39 years-old Exclusion Criteria: - Subject taking psychotropic drug during the two weeks before the inclusion - Subject with following medical history : NREM parasomnia, neurologic or psychiatric disorder, obstructive sleep apnea syndrome, restless legs syndrome, nocturnal epilepsy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Single-photon emission computed tomography


Locations

Country Name City State
France University Hospital of Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brain metabolism measurement with brain scintigraphy Day 0
Secondary Cortical excitability measurement with transcranial magnetic stimulation Day 0
See also
  Status Clinical Trial Phase
Withdrawn NCT02906904 - Pain Sensitivity in NREM Parasomnia (NOCISOMNIE) N/A
Recruiting NCT05452733 - Toward a Real-time Access to Sleepers' Mental Content N/A
Completed NCT02648568 - Does Hypnosis Improve Severe Sleepwalking ? N/A